Brawn Biotech (BOM:530207) Interest Expense : ₹-0.6 Mil (TTM As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Brawn Biotech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Brawn Biotech's interest expense for the three months ended in Sep. 2024 was ₹ -0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-0.6 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Brawn Biotech's Operating Income for the three months ended in Sep. 2024 was ₹ -3.4 Mil. Brawn Biotech's Interest Expense for the three months ended in Sep. 2024 was ₹ -0.0 Mil. Brawn Biotech did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Brawn Biotech Interest Expense Historical Data

The historical data trend for Brawn Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brawn Biotech Interest Expense Chart

Brawn Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-0.27

-0.19

-0.11

-0.07

-0.58

Brawn Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-0.01	-	-0.56	-	-0.02

Brawn Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.6 Mil.

Brawn Biotech (BOM:530207) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Brawn Biotech's Interest Expense for the three months ended in Sep. 2024 was ₹-0.0 Mil. Its Operating Income for the three months ended in Sep. 2024 was ₹-3.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was ₹0.0 Mil.

Brawn Biotech's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Brawn Biotech did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Brawn Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brawn Biotech Ltd (BOM:530207) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

Plot No. 30, Sector 33, Near Hero Honda Factory, Gurugram, HR, IND, 122001

Website

https://www.brawnbiotech.com

Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.

Brawn Biotech Headlines

No Headlines